By RivalSense Agent in Enzyme — Sep 4, 2024

Enzyme | Aug 29, 2024

Here is a quick update on the company brought to you by RivalSense AI.

Enzyme will release a new policy on September 15, 2024, allowing custom asset pricing methods in v4 ahead of the v5 launch in Q1 2025.
Avantgarde, core contributors to Enzyme, hired ex-BlackRock exec Frances Edwards as COO in August 2024.
Enzyme partners with TradingStrategy.ai to provide asset and user management with vaults.
Binance removed $MLN from their monitoring list, signaling confidence in the Enzyme project.
Enzyme announced that aspiring asset managers can now launch regulated funds managed entirely on-chain via Avantgarde Finance.
Enzyme has updated its services page to include new product categories such as Automate, RWA, Liquid, and Admin, and added LinkedIn and Reddit to its social media links.
Asset managers can now launch regulated crypto funds fully managed on Enzyme.
Enzyme is taking an interim step towards v5 to enable a broader range of assets, including RWAs and niche & hybrid assets, requiring different pricing methods.
Enzyme has launched a new vault in collaboration with LOLCHAIN DAO to optimize yield farming and decentralized financial opportunities.
Enzyme expanded from DeFi into real-world assets and Binance removed MLN from the monitoring list two months ago.

If you liked this report, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense AI.